17 research outputs found

    Current and Nascent SETI Instruments

    Get PDF
    Here we describe our ongoing efforts to develop high-performance and sensitive instrumentation for use in the search for extra-terrestrial intelligence (SETI). These efforts include our recently deployed Search for Extraterrestrial Emissions from Nearby Developed Intelligent Populations Spectrometer (SERENDIP V.v) and two instruments currently under development; the Heterogeneous Radio SETI Spectrometer (HRSS) for SETI observations in the radio spectrum and the Optical SETI Fast Photometer (OSFP) for SETI observations in the optical band. We will discuss the basic SERENDIP V.v instrument design and initial analysis methodology, along with instrument architectures and observation strategies for OSFP and HRSS. In addition, we will demonstrate how these instruments may be built using low-cost, modular components and programmed and operated by students using common languages, e.g. ANSI C.Comment: 12 pages, 5 figures, Original version appears as Chapter 2 in "The Proceedings of SETI Sessions at the 2010 Astrobiology Science Conference: Communication with Extraterrestrial Intelligence (CETI)," Douglas A. Vakoch, Edito

    The ACS Fornax Cluster Survey VII. Half-Light Radii of Globular Clusters in Early-Type Galaxies

    Get PDF
    We measure the half-light radii of globular clusters (GCs) in 43 galaxies from the ACS Fornax Cluster Survey (ACSFCS). We use these data to extend previous work in which the environmental dependencies of the half-light radii of GCs in early type galaxies in the ACS Virgo Cluster Survey (ACSVCS) were studied, and a corrected mean half-light radius (corrected for the observed environmental trends) was suggested as a reliable distance indicator. This work both increases the sample size for the study of the environmental dependencies, and adds leverage to the study of the corrected half-light radius as a possible distance indicator (since Fornax lies at a larger distance than the Virgo cluster). We study the environmental dependencies of the size of GCs using both a Principal Component Analysis as well as 2D scaling relations. We largely confirm the environmental dependencies shown in Jordan et al. (2005), but find evidence that there is a residual correlation in the mean half-light radius of GC systems with galaxy magnitude, and subtle differences in the other correlations - so there may not be a universal correction for the half-light radii of lower luminosity galaxy GC systems. The main factor determining the size of a GC in an early type galaxy is the GC color. Red GCs have = 2.8+/-0.3 pc, while blue GCs have = 3.4+/-0.3 pc. We show that for bright early-type galaxies (M_B < -19 mag), the uncorrected mean half-light radius of the GC system is by itself an excellent distance indicator (with error ~11%), having the potential to reach cosmologically interesting distances in the era of high angular resolution adaptive optics on large optical telescopes.Comment: ApJ in press, 19 pages, 16 figures

    The ACS Fornax Cluster Survey. IX. The Color-Magnitude Relation of Globular Cluster Systems

    Get PDF
    We investigate the color-magnitude relation for globular clusters (GCs) -- the so-called "blue tilt" -- detected in the ACS Fornax Cluster Survey and using the combined sample of GCs from the ACS Fornax and Virgo Cluster Surveys. We find a tilt of gamma_z=d(g-z)/dz=-0.0257 +- 0.0050 for the full GC sample of the Fornax Cluster Survey (~5800 GCs). This is slightly shallower than the value gamma_z=-0.0459 +- 0.0048 found for the Virgo Cluster Survey GC sample (~11100 GCs). The slope for the merged Fornax and Virgo datasets (~16900 GCs) is gamma_z=-0.0293 +- 0.0085, corresponding to a mass-metallicity relation of Z ~ M^0.43. We find that the blue tilt sets in at GC masses in excess of M ~ 2*10^5 M_sun. The tilt is stronger for GCs belonging to high-mass galaxies (M_* > 5 * 10^10 M_sun) than for those in low-mass galaxies (M_* < 5 * 10^10 M_sun). It is also more pronounced for GCs with smaller galactocentric distances. Our findings suggest a range of mass-metallicity relations Z_GC ~ M_GC^(0.3-0.7) which vary as a function of host galaxy mass/luminosity. We compare our observations to a recent model of star cluster self-enrichment with generally favorable results. We suggest that, within the context of this model, the proto-cluster clouds out of which the GCs formed may have had density profiles slightly steeper than isothermal and/or star formation efficiencies somewhat below 0.3. We caution, however, that the significantly different appearance of the CMDs defined by the GC systems associated with galaxies of similar mass and morphological type pose a challenge to any single mechanism that seeks to explain the blue tilt. We therefore suggest that the merger/accretion histories of individual galaxies have played a non-negligible role determining the distribution of GCs in the CMDs of individual GC systems

    Program Welcome

    Full text link

    Program Welcome

    Full text link

    Renaissance of Annulene Chemistry

    Full text link

    A 2D Covalent Organic Framework with 4.7-nm Pores and Insight into Its Interlayer Stacking

    Full text link
    Two-dimensional layered covalent organic frameworks (2D COFs) organize π-electron systems into ordered structures ideal for exciton and charge transport and exhibit permanent porosity available for subsequent functionalization. A 2D COF with the largest pores reported to date was synthesized by condensing 2,3,6,7,10,11-hexahydroxytriphenylene (HHTP) and 4,4′-diphenylbutadiynebis(boronic acid) (DPB). The COF was prepared as both a high surface area microcrystalline powder as well as a vertically oriented thin film on a transparent single-layer graphene/fused silica substrate. Complementary molecular dynamics and density functional theory calculations provide insight into the interlayer spacing of the COF and suggest that adjacent layers are horizontally offset by 1.7–1.8 Å, in contrast to the eclipsed AA stacking typically proposed for these materials

    Clinical responses of oncolytic coxsackievirus A21 (V937) in patients with unresectable melanoma

    Full text link
    PURPOSE: We evaluated the activity of intratumoral Coxsackievirus A21 (V937) in 57 patients with unresectable stage IIIC or IV melanoma. PATIENTS AND METHODS: In this multicenter, open-label, phase II study, patients received up to a total V937 dose of 3 × 108 TCID50 (50% tissue culture infectious dose) in a maximum 4.0-mL volume by intratumoral injection. Ten sets of V937 injections were administered between days 1 and 127 (NCT01227551). Patients who had stable disease or were responding could continue treatment in an extension study (NCT01636882). Response and progression status were based on contrast-enhanced computed tomography, magnetic resonance imaging, or caliper measurement and were categorized using immune-related Response Evaluation Criteria in Solid Tumors (irRECIST). Other evaluations included monitoring of adverse events and serum levels of V937 and anti-V937 antibody titers. The primary efficacy end point was 6-month progression-free survival (PFS) rate per irRECIST. RESULTS: The primary efficacy end point, 6-month PFS rate per irRECIST, was 38.6% (95% CI, 26.0 to 52.4). Durable response rate (partial or complete response for ≥ 6 months) was 21.1% per irRECIST. Best overall response rate (complete plus partial response) was 38.6% (unconfirmed) and 28.1% (confirmed) per irRECIST. Regression of melanoma was observed in noninjected lesions. Based on Kaplan-Meier estimation, 12-month PFS was 32.9% (95% CI, 19.5 to 46.9) per irRECIST and 12-month overall survival was 75.4% (95% CI, 62.1 to 84.7). No treatment-related grade ≥ 3 adverse events occurred. Viral RNA was detected in serum within 30 minutes of administration. Neutralizing antibody titers increased to \u3e 1:16 in all patients after day 22, without effect on clinical or immunologic response. CONCLUSION: V937 was well tolerated and warrants further investigation for treatment of patients with unresectable melanoma. Studies of combination approaches with V937 and immune checkpoint inhibitors are ongoing
    corecore